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In recent years, HIV-1 integrase (IN) has become an attractive target for designing antiretroviral agents. The
development of raltegravir and other successful lead IN inhibitors has also influenced the IN inhibitor design
strategy. This has led to the identification of several potent inhibitors in these last 2 years. The medicines which
have the compound of C-centered and N-centered anti-HIV inhibitor with single-walled carbon nanotube are
examined by density functional theory (DFT) method. In this paper, the end of the nanotubes, which was saturated
with hydrogen atoms, was examined by DFT at the level of B3LYP and 6-31G(d) standard basis set. There are free
Gibbs energy, free Helmholtz energy, enthalpy, bond length (Å), bond angle (in degrees), dihedral angle (in
degrees), energy hyperconjugation, total energy (in Kcal mol−1), moment dipole (in Debye), occupancy between
nanotube (6, 6), and chalcone derivative. These cases and medicines show that complex 2 is more stable than the
other complexes.
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Since the discovery of carbon nanotubes by Iijima [1],
extensive research has been devoted to their structural
characterization [2]. Among the numerous delivery sys-
tems currently under investigations, carbon nanotubes
(CNTs) seem to embody a promising option [3]. Pristine
carbon nanotubes (pCNTs) are made up of carbon
atoms arranged in a series of condensed benzene rings
and wrapped into a tubular form (Figure 1). Concerning
their use in biological systems, lack of solubility (both in
organic solvents and aqueous solutions), formation of
thick and inhomogeneous bundles, circulation half-life
of 3 to 3.5 h [4], and biocompatibility and immunogen-
icity limitations raise great concerns. However, these
observations hold only for pCNTs and, therefore, just
indicate the need for further modifications in order to
explore the feasibility of functionalized CNTs (f-CNTs)
as safe bio-nanomaterial [5,6]. In particular, the applica-
tion of f-CNTs as new nanovectors for drug delivery be-
came doable soon after the demonstration of cellular
uptake of this new material [7,8]. It is worth to mention
that apart from a few cases of phagocytic incorporation
inside macrophages [9,10] (which are known to be large
cleaning cells able to remove foreign material including
less soluble nanotubes), no uncoated pCNTs were* Correspondence: s.ghorbani.uni@gmail.com
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distribution, and reproduction in any medium,reported to penetrate inside the cells without displaying
remarkable effect. This last point should reinforce the
use of f-CNTs as improved, less harmful nanovehicles,
especially after our recent discovery regarding the lack
of a direct correlation between the kind of functio-
nalization on the surface of carbon nanotubes and the
extent of their internalization [11-13]: either electrosta-
tically neutral or charged f-CNTs could be taken up by
cells with comparable amount, hence indicating that nu-
merous different chemical procedures could be adapted
to introduce several groups and functionalities. Further,
an increased understanding of IN structural biology has
opened up novel approaches to inhibit IN, such as
targeting its multimerization or interaction with cellular
cofactors [14]. In the paper, complex between chalcone
and nanotube (6, 6) is investigated, and chalcone is used
as anti-HIV drug. The chemistry of chalcones has gen-
erated intensive scientific studies throughout the world.
Special interest has been focused on the synthesis and
biodynamic activities of chalcones. The term ‘chalcones’
was given by Kostanecki and Tambor [15]. These
compounds are also known as benzalacetophenone or
benzylidene acetophenone. In chalcones, two aromatic
rings are linked by an aliphatic three carbon chain.
Chalcone bears a very good synthon, so a variety of
novel heterocycles with good pharmaceutical profile
can be designed. Chalcones are α- and β-unsaturatedlicensee Springer. This is an Open Access article distributed under the terms of
p://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
provided the original work is properly cited.
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Figure 1 The optimized complex of chalcone derivative - SWCNT (6, 6) in B3LYP/6-31G(d) method at 298.15K.
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CO-CH=CH-. These are colored compounds because of
the presence of the chromospheres -CO-CH=CH-,
which depend in the presence of other auxochromes.
Chalcones resemble the diketo acid functionality and
are potential leads in designing potent IN inhibitors.
Potent chalcones were identified through an NCI drug
screening program [16]. The structures of chalcone are
shown in Figure 2.
Results and discussion
We measured the parameters such as bond length (Å),
natural bond orbital (NBO), and bond angle, dihedral
angle, distances of analyzed models of the SWCNT
(6, 6). The end of the nanotubes, which was saturated
with hydrogen atoms, was examined by DFT at the
level of B3LYP and 631G(d) standard basis set and is
shown in Tables 1, 2, and 3. The electron that is given
by the complexes in a reaction should make it as
HOMO, while that which captured the complexes
must be placed on its LUMO [17], so the atom on
which the HOMO mainly scattered should be able
to separate the electrons, while the atom, by holdingthe LUMO, should achieve electrons on this basis.
HOMO-LUMO gap is usually associated with chemical
stability against electronic excitation with a larger dis-
tance like greater stability [18]. The energy (kcal mol−1)
and dipole moments (Debye) indicate the consistency
among the three complex calculations in the DFT
method. The optimized configurations are shown in
Figures 1 and 2. In Table 1, it becomes obvious that the
complexes 2 and 3 have higher hyperconjugation energy
than complex 1. The results also show that as the P in-
creases through the sharing of hybrid atoms, the occu-
pancy decreases. The hybrid s orbital shared in the
oxygen atom in complex 3 is more than the hybrid s or-
bital shared in complexes 1 and 2. Most of the com-
bined energy hyperconjugations are stable. Occupancy
coefficient is smaller. Complex 2 is more stable than
complexes 1 and 3. The energy hyperconjugation of
complex 2 (21.25) is lesser than that of complex3. Re-
duced coupling energy is due to the resonance
interference.
Based on the drug resonance structure, a phenolic
ring is observed. In complex 2, the negative charge is
located in orthoposition. However, in complex 3, the
negative charge is in the oxygen group (OH). Thus,






(E)-1 - (2, 4-hydroxyphenyl)-3 -(2-hydroxyphenyl) prop-2-en-1-one
Figure 2 The structures of chalcone derivative. Optimizations were performed by B3LYP/6-31G(d) method at 298 K.
(a) (Z)-4-(3-fluoro-4-methylbenzylamino)-2-hydroxy-4-oxobut-2-enoic acid. (b) (E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one.
(c) (E)-1-(2, 4-hydroxyphenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one.
Table 1 The parameters of NBO complexes 1, 2, and 3 by B3LYP/631G(d) method at 298.15 K
Agent Acceptor Occupancy Donor Occupancy Hybrid ΣE2
Complex 1 σ* C28-30 LP(1)O84 0.03683 21.27
π* C29-30 1.93552 LP(1)O84 0.23326 sp1.84
σ* C28-30 1.84587 LP(2)O84 0.03683 sp99.99
σ* C29-30 LP(2)O84 0.02234
π* C29-30 LP(2)O84 0.23326
Complex 2 σ* C28-30 LP(1)O84 0.03694 21.25
π* C29-30 1.93477 LP(1)O84 0.23167 sp1.99
σ* C28-30 1.84823 LP(2)O84 0.03694 sp12.91
σ* C29-30 LP(2)O84 0.02252
π* C29-30 LP(2)O84 0.23167
Complex 3 σ* C28-30 LP(1)O84 0.03705 25.67
π* C29-30 1.93368 LP(1)O84 0.24195 sp1.87
σ* C28-30 1.84353 LP(2)O84 0.03705 sp1.00
σ* C29-30 LP(2)O84 0.02139
π* C29-30 LP(2)O84 0.24195
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Table 2 The parameter of bond distances, bond angles, and torsional angles in B3LYP/631G(d) method optimized
complexes 1, 2, and 3 at 298.15 K
Agent Complex1 Complex 2 Complex3
C30O84 1.38360 1.38918 1.38844
O84C85 1.36355 1.37733 1.37905
C85…C87/86 1.50671 1.41639 1.41556
C85=C86 or C85…C87 1.34399 - 1.39631
C88…N92 1.37423 - -
C88=C92 - 1.35015 1.34867
C88=O93/92 1.22636 1.33211 -
C95/92-C97 1.51805 1.48257 1.49038
C97=O101 - 1.23025 1.22693
C89/88H93 - 1.08671 1.08697
C97C101/100 1.40144 1.50356 1.49705
C102F107 1.35539 - -
C108O112 - - 1.3632
N92C95 1.46093 - -
C30O84C85 119.49672 119.98567 119.72205
O84C85/95…C86 122.94446 115.99633 116.00968
C85…C86…H89/C89 115.63440 117.35796 117.31516
C86C89=N92/C92 112.89707 127.05408 126.82625
C92C97=C101/O101 120.54112 121.23147 121.14706
C100…C103F/O/H107
1 118.48520 117.99263 118.85317
C30O84C85…C87
2 65.15798 10.06339 10.44740
C85=C86C89N92/H95
3 −171.74691 178.34956 178.08447
C28…C30O84C85
4 −160.04093 74.54557 75.32017
C106 .…C108O112H113
5 - - 179.82075
C88 …N92C95F107
6 179.93485 - 1.32961
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is lower. The occupancy factor is larger. In complex 2,
the hybrid and occupancy are sp1.88 and 1.9355,
respectively.
The calculations of the total energies and energy
hyperconjugation (E2) of the optimized structures, di-
pole moments (μ), occupancy, and hybrid orbital at
B3LYP/631G(d) levels are presented in Tables 2 and 3.
The DFT calculated geometric parameters for com-
plexes 1, 2, and 3 are compared in Table 2. The bondTable 3 The parameter of Mulliken charge, energy HOMO/
298.15 K
Agent C30 Mulliken charge Energy of
HOMO (Kcal mol−1)
Complex 1 0.282424 −0.1579
Complex 2 0.282510 −0.1567
Complex 3 0.291184 −0.1538lengths of C30-O84 calculated for complexes 1, 2, and 3
at the DFT level are 1.383, 1.389, and 1.388 Å, respect-
ively at the B3LYP/631G(d) level. The bond length of
C85…C87 for complex 1 is 1.50671 Å; for complexes 2
and 3, 1.41639 and 1.41556 Å, respectively. The bond
length of C88… N92 (1.37423 Å) in complex 1 is lower
than the bond length of C88=C92 in complexes 2
(1.35015 Å) and 3 (1.34867 Å). This is because the
electronegative nitrogen is bigger than carbon. The
bond length of C88=O93/92 in complexes 1 and 2 areLUMO and gap energy in B3LYP/631G(d) method at























Figure 3 Parameter of dihedral angle change to locations 1, 2, 3, 4, 5, and 6 of complexes 1, 2, and 3 formed in B3LYP/631g(d)
method at 298.15 K.
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C=C, C…N in complexes 2, 3, and 1. The dihedral an-
gles of C100…C103F/O/H107
1 for complexes 1, 2, and 3
are 118.48520°, 117.99263°, and 118.85317° (in F, O,
and H atoms). In locations 1, 2, 3, 4, 5, and 6, the
hydra angle differences are observed in Table 1 and
Figure 3. In Table 3, the Mulliken charges in donor
electronegative atom O84 and acceptor C30 are negative
and positive, respectively. The gap of energy of com-
plex 2 is larger than that of complexes 1 and 3. There-
fore, complex 2 is stable (Table 4).
Conclusions
Based on the above discussion, the following conclusions
were made:
 The Mulliken charges of the donor atoms are
negative.
 The formed bond between oxygen and carbon is
stronger and has more hybrid S orbital sharing,
so the bond length becomes shorter.
 There is no reaction between the nanotube and
drugs in the normal body temperature.
 NBO analysis shows high hyperconjugations in all
compounds.
 By increasing the hybrid P orbital sharing, the
occupancy decreases.Table 4 Comparison between stability energy and
moment dipole of complexes 1, 2, and 3 formed in
B3LYP/631g(d) method at 298.15 K
Agent Stability energy (Kcal mol−1) Dipole moment (Debye)
Complex 1 −1,900,685.711 −0.2357
Complex 2 −1,995,192.983 1.09133
Complex 3 −1,972,541.490 0.5679Methods
A computer was used to account all calculations, which
has Intel® Core™ 2 quad CPU 8400 with 4 GB RAM
Gaussian 98 plan package [19] Gauss view, and nano-
tube model [20] maker at DFT of theory, the B3LYP
useful hybrid [21] with the standard of 631G(d) basis set
[22,23]. Schemes were used to display the geometric
optimization of the nanotube (6, 6) with 84 atoms and
compound chalcones (HIV-1 inhibitors). Separately
(Figures 1, 2, and 3) then, complexes 1,2, and 3 were
formed. The reaction of the nanotube and chalcone is
shown in Equation 1.
Chalcone
þNanotube 6; 6ð ÞChalcone−Nanotube 6; 6ð Þ
þH2 ð1Þ
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